{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:04:59Z","timestamp":1785416699614,"version":"3.56.0"},"reference-count":28,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust, UK","doi-asserted-by":"crossref","award":["209075\/Z\/17\/Z"],"award-info":[{"award-number":["209075\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council (Joint Global Health Trials","award":["MR\/V004832\/1"],"award-info":[{"award-number":["MR\/V004832\/1"]}]},{"DOI":"10.13039\/100032626","name":"Unitaid","doi-asserted-by":"crossref","award":["2022-50-START-4-ALL"],"award-info":[{"award-number":["2022-50-START-4-ALL"]}],"id":[{"id":"10.13039\/100032626","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PHIND","award":["MR\/Y503216\/1"],"award-info":[{"award-number":["MR\/Y503216\/1"]}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MRF-131-0006-RG-KHOS-C0942"],"award-info":[{"award-number":["MRF-131-0006-RG-KHOS-C0942"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,15]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Tuberculosis (TB) remains underdiagnosed in many high-burden countries due to high costs and limited availability of rapid molecular tests. Globally, only half of people with TB receive a molecular test as their initial diagnostic test. Pooled testing combines sputum samples from multiple individuals into a single molecular assay, offering cost savings by optimising existing resources, particularly in resource-constrained health systems. Although pooled sputum testing has now been recommended by the World Health Organization in 2026, evidence on real-world feasibility and acceptability for people with TB and healthcare providers remains limited. This study explored multisectoral stakeholder perspectives on the feasibility and acceptability of pooled sputum testing for TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicountry qualitative study using key informant interviews and focus group discussions. Data were analysed using a framework approach guided by established feasibility and acceptability models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Facility and community settings across seven high-TB-burden countries: Bangladesh, Brazil, Cameroon, Kenya, Malawi, Nigeria, and Viet Nam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Thirty-eight key informant interviews and 18 focus group discussions were conducted with National TB Programme (NTP) representatives, laboratory technicians, people with TB and international experts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pooled testing was considered feasible and acceptable in facility and community settings with greater confidence in countries with prior implementation experience. Feasibility depended on alignment with diagnostic algorithms and laboratory workflows, biosafety, training and clear standard operating procedures.<\/jats:p>\n                    <jats:p>Acceptability operated at two levels: early NTP engagement with healthcare providers to secure professional buy-in and clear communication between healthcare providers and people undergoing testing to support understanding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pooled testing was considered feasible and acceptable in settings with robust laboratory systems and routine practices. Readiness varied across countries, with some suitable for rapid implementation and scale-up while others required system strengthening. In settings perceived as having suitable infrastructure and readiness, pooled testing was viewed as a pragmatic strategy to optimise molecular TB testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-120434","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:45:25Z","timestamp":1785415525000},"page":"e120434","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and acceptability of pooled sputum testing for tuberculosis: a multicountry qualitative study of the Start4All project"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-1402","authenticated-orcid":false,"given":"Vibol","family":"Iem","sequence":"first","affiliation":[{"name":"Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-6286","authenticated-orcid":false,"given":"Luan Nguyen Quang","family":"Vo","sequence":"additional","affiliation":[{"name":"Friends for International TB Relief, Hanoi, Viet Nam"},{"name":"Department of Global Public Health, Karolinska Institute, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Codlin","sequence":"additional","affiliation":[{"name":"Friends for International TB Relief, Hanoi, Viet Nam"},{"name":"Department of Global Public Health, Karolinska Institute, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosunmola","family":"Iwakun","sequence":"additional","affiliation":[{"name":"Zankli Research Centre, Bingham University, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimwemwe","family":"Kwanjo Banda","sequence":"additional","affiliation":[{"name":"Malawi-Liverpool-Wellcome Clinical Research Programme, Blantyre, Southern Region, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Akunda","family":"Okelloh","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Mbuli","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research, Bamenda, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Santana","family":"Dosea","sequence":"additional","affiliation":[{"name":"Pharmacy Program, Department of Health, State University of Feira de Santana (UEFS), Feira de Santana, Bahia (BA), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Santana","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Federal University of Sergipe, Lagarto, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal Ibne Amin","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Garg","sequence":"additional","affiliation":[{"name":"Stop TB Partnership, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Creswell","sequence":"additional","affiliation":[{"name":"Stop TB Partnership, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-3145","authenticated-orcid":false,"given":"Beate","family":"Ringwald","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I","family":"Cubas Atienzar","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, England, UK"},{"name":"Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-3125","authenticated-orcid":false,"given":"Rachel L","family":"Byrne","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wingfield","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, England, UK"},{"name":"Department of Global Public Health, Karolinska Institute, Stockholm, Stockholm County, Sweden"},{"name":"Tropical and Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2026073005450976000_16.7.e120434.1","unstructured":"World health organization . Global tuberculosis report 2025. Geneva, Switzerland World Health Organization; 2025."},{"key":"2026073005450976000_16.7.e120434.2","doi-asserted-by":"crossref","first-page":"e1184","DOI":"10.1016\/S2214-109X(24)00148-7","article-title":"Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research","volume":"12","author":"Broger","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026073005450976000_16.7.e120434.3","unstructured":"Start taking action for TB diagnosis. ClinicalTrials.gov; 2023."},{"key":"2026073005450976000_16.7.e120434.4","doi-asserted-by":"crossref","DOI":"10.1186\/s44263-024-00063-4","article-title":"Finding the missed millions: innovations to bring tuberculosis diagnosis closer to key populations","volume":"2","author":"Byrne","year":"2024","journal-title":"BMC Glob Public Health"},{"key":"2026073005450976000_16.7.e120434.5","article-title":"Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents","volume":"8","author":"Kohli","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"2026073005450976000_16.7.e120434.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"2026073005450976000_16.7.e120434.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012666","article-title":"Achieving universal access to rapid tuberculosis diagnostics","volume":"8","author":"Ismail","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2026073005450976000_16.7.e120434.8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3201\/eid2703.204090","article-title":"Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB\/RIF Tuberculosis Testing during the COVID-19 Pandemic","volume":"27","author":"Cuevas","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2026073005450976000_16.7.e120434.9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-2600(25)00328-5","article-title":"Pooled testing for TB: revisiting a cost-saving innovation","volume":"13","author":"Iem","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026073005450976000_16.7.e120434.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.01.009"},{"key":"2026073005450976000_16.7.e120434.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000116","article-title":"Pooling sputum for Xpert MTB\/RIF and Xpert Ultra testing during the Covid-19 pandemic in Lao People\u2019s Democratic Republic","volume":"2","author":"Iem","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026073005450976000_16.7.e120434.12","doi-asserted-by":"publisher","DOI":"10.5588\/pha.22.0052"},{"key":"2026073005450976000_16.7.e120434.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08330-9","article-title":"Pooling sputum testing to diagnose tuberculosis using xpert MTB\/RIF and xpert ultra: a cost-effectiveness analysis","volume":"23","author":"Iem","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026073005450976000_16.7.e120434.14","doi-asserted-by":"crossref","unstructured":"Garg T , Sander M , Byrne R , et al . Diagnostic performance and test savings of pooled testing for molecular detection of tuberculosis: a diagnostic accuracy study across seven countries [Preprint], 2026: https:\/\/ssrn.com\/abstract=6554878","DOI":"10.2139\/ssrn.6554878"},{"key":"2026073005450976000_16.7.e120434.15","unstructured":"World Health Organization . Public call for data to inform who policy updates on new TB diagnostic samples, tests, and testing strategies. 2025. Available: https:\/\/www.who.int\/news-room\/articles-detail\/public-call-for-data-to-inform-who-policy-updates-on-new-tb-diagnostic-samples--tests--and-testing-strategies"},{"key":"2026073005450976000_16.7.e120434.16","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2026073005450976000_16.7.e120434.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-021-01171-7","article-title":"Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework","volume":"17","author":"Klaic","year":"2022","journal-title":"Implement Sci"},{"key":"2026073005450976000_16.7.e120434.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-016-0374-x","article-title":"A framework for scaling up health interventions: lessons from large-scale improvement initiatives in Africa","volume":"11","author":"Barker","year":"2016","journal-title":"Implement Sci"},{"key":"2026073005450976000_16.7.e120434.19","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-38"},{"key":"2026073005450976000_16.7.e120434.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2026073005450976000_16.7.e120434.21","unstructured":"Jackson K . Qualitative Data Analysis with NVivo 3rd ed. Thousand Oaks, CA: SAGE Publications, 2019."},{"key":"2026073005450976000_16.7.e120434.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41904-w","article-title":"Implementation of large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation","volume":"13","author":"Vuchas","year":"2023","journal-title":"Sci Rep"},{"key":"2026073005450976000_16.7.e120434.23","doi-asserted-by":"publisher","DOI":"10.1177\/0038038509103208"},{"key":"2026073005450976000_16.7.e120434.24","unstructured":"World Health Organization . WHO Operational Handbook on Tuberculosis. Module 3: Diagnosis. Geneva: World Health Organization, 2025."},{"key":"2026073005450976000_16.7.e120434.25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.12688\/f1000research.152755.2","article-title":"Workload Assessment of Technical Staff in a Clinical Laboratory in South India","volume":"13","author":"Thomas","year":"2025","journal-title":"F1000Res"},{"key":"2026073005450976000_16.7.e120434.26","unstructured":"World Health Organization . Practical Manual on Tuberculosis Laboratory Strengthening. Geneva: World Health Organization, 2022."},{"key":"2026073005450976000_16.7.e120434.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321690","article-title":"A qualitative systematic review of barriers and facilitators to the implementation of community-based molecular diagnostics for infectious diseases","volume":"20","author":"Nelson","year":"2025","journal-title":"PLoS One"},{"key":"2026073005450976000_16.7.e120434.28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/dx-2020-0112","article-title":"Measuring patient experience of diagnostic care and acceptability of testing","volume":"8","author":"Forster","year":"2021","journal-title":"Diagnosis (Berl)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-120434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:45:31Z","timestamp":1785415531000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-120434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,30]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-120434"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-120434","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}